Literature DB >> 20207456

Hemolysis in a patient with alkaptonuria and chronic kidney failure.

Anne-Elisabeth Heng1, Marie Courbebaisse, Jean Louis Kemeny, Raluca Matesan, Claude Bonniol, Patrice Deteix, Bertrand Souweine.   

Abstract

In alkaptonuria, the absence of homogentisic acid oxidase results in the accumulation of homogentisic acid (HGA) in the body. Fatal disease cases are infrequent, and death often results from kidney or cardiac complications. We report a 24-year-old alkaptonuric man with severe decreased kidney function who developed fatal metabolic acidosis and intravascular hemolysis. Hemolysis may have been caused by rapid and extensive accumulation of HGA and subsequent accumulation of plasma soluble melanins. Toxic effects of plasma soluble melanins, their intermediates, and reactive oxygen side products are increased when antioxidant mechanisms are overwhelmed. A decrease in serum antioxidative activity has been reported in patients with chronic decreased kidney function. However, despite administration of large doses of an antioxidant agent and ascorbic acid and intensive kidney support, hemolysis and acidosis could not be brought under control and hemolysis led to the death of the patient.

Entities:  

Mesh:

Year:  2010        PMID: 20207456     DOI: 10.1053/j.ajkd.2009.11.023

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

1.  Fatal methemoglobinemia complicating alkaptonuria (ochronosis): a rare presentation.

Authors:  Amanda R Freeman; Stephen M Wills
Journal:  Forensic Sci Med Pathol       Date:  2018-03-23       Impact factor: 2.007

Review 2.  Alkaptonuria in France: past experience and lessons for the future.

Authors:  Robert Raphael Aquaron
Journal:  J Inherit Metab Dis       Date:  2011-09-17       Impact factor: 4.982

Review 3.  Acute fatal metabolic complications in alkaptonuria.

Authors:  A S Davison; A M Milan; J A Gallagher; L R Ranganath
Journal:  J Inherit Metab Dis       Date:  2015-11-23       Impact factor: 4.982

4.  Impact of chronic kidney disease on the natural history of alkaptonuria.

Authors:  Bernardo Faria; Joana Vidinha; Cátia Pêgo; Hugo Correia; Tânia Sousa
Journal:  Clin Kidney J       Date:  2012-08

5.  Fatal oxidative haemolysis and methaemoglobinaemia in a patient with alkaptonuria and acute kidney injury.

Authors:  Adam Mullan; Derek Cocker; Gordon Taylor; Colin Millar; Lakshminarayan Ranganath
Journal:  Clin Kidney J       Date:  2014-11-17

6.  Fatal acute haemolysis and methaemoglobinaemia in a man with renal failure and Alkaptonuria - Is nitisinone the solution?

Authors:  A S Davison; E Luangrath; E Selvi; L R Ranganath
Journal:  Mol Genet Metab Rep       Date:  2020-04-16

7.  Alkaptonuria is a novel human secondary amyloidogenic disease.

Authors:  Lia Millucci; Adriano Spreafico; Laura Tinti; Daniela Braconi; Lorenzo Ghezzi; Eugenio Paccagnini; Giulia Bernardini; Loredana Amato; Marcella Laschi; Enrico Selvi; Mauro Galeazzi; Alessandro Mannoni; Maurizio Benucci; Pietro Lupetti; Federico Chellini; Maurizio Orlandini; Annalisa Santucci
Journal:  Biochim Biophys Acta       Date:  2012-07-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.